Login to Your Account

Clinic Roundup

Friday, December 10, 2010
• BioDelivery Sciences International Inc., of Raleigh, N.C., enrolled and dosed the first patient in its Phase III trial of BEMA buprenorphine for chronic pain. Results are expected in the third quarter of 2011.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription